GLP-1s are basically appetite’s off-switch: suddenly you’re “full” after three bites. Congrats on the smaller meals and ...

These will help you build a supportive foundation for the body.

The US Food and Drug Administration (FDA) has instructed all GLP-1 drug-makers to update their warning labels to include the risk of serious kidney injury that can result from dehydration. This comes ...

One of the biggest risk factors for prediabetes is weight gain. Over the past several decades, rates of obesity have risen ...

GLP-1 receptor agonists like semaglutide and tirzepatide have redefined what’s possible in the treatment of obesity and metabolic syndrome. These medications have shown remarkable results in appetite ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

Psoriasis and psoriatic arthritis (PsA) are chronic, immune-mediated inflammatory diseases associated with several shared common comorbidities, of which obesity is one of the most prevalent. A complex ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

Learn how to prevent muscle loss while taking GLP-1 medications, with expert tips on protein intake, strength training, and body composition monitoring.

Oprah Winfrey has spoken openly about using GLP-1s to lose weight in the last few years ...